Currency in USD
| Earnings Estimate | Current Qtr. (Feb 2023) | Next Qtr. (May 2023) | Current Year (2023) | Next Year (2024) |
|---|
| No. of Analysts | 0 | 0 | 0 | 0 |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0.01 | -0.02 | N/A | N/A |
| Revenue Estimate | Current Qtr. (Feb 2023) | Next Qtr. (May 2023) | Current Year (2023) | Next Year (2024) |
|---|
| No. of Analysts | 1 | 0 | 1 | 1 |
| Avg. Estimate | N/A | N/A | 90k | N/A |
| Low Estimate | N/A | N/A | 90k | N/A |
| High Estimate | N/A | N/A | 90k | N/A |
| Year Ago Sales | N/A | N/A | 28.5k | 90k |
| Sales Growth (year/est) | N/A | N/A | 215.80% | N/A |
| Earnings History | 2021-08-30 | 2021-11-29 | 2022-02-27 | 2022-11-29 |
|---|
| EPS Est. | -0.01 | -0.02 | -0.02 | -0.01 |
| EPS Actual | -0.01 | -0.02 | -0.01 | -0.01 |
| Difference | 0 | 0 | 0.01 | 0 |
| Surprise % | 0.00% | 0.00% | 50.00% | 0.00% |
| EPS Trend | Current Qtr. (Feb 2023) | Next Qtr. (May 2023) | Current Year (2023) | Next Year (2024) |
|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | -0.01 | 0 | -0.05 | -0.05 |
| 30 Days Ago | -0.01 | 0 | -0.05 | -0.05 |
| 60 Days Ago | -0.01 | 0 | -0.05 | -0.05 |
| 90 Days Ago | -0.01 | 0 | -0.05 | -0.05 |
| EPS Revisions | Current Qtr. (Feb 2023) | Next Qtr. (May 2023) | Current Year (2023) | Next Year (2024) |
|---|
| Up Last 7 Days | N/A | N/A | N/A | N/A |
| Up Last 30 Days | N/A | N/A | N/A | N/A |
| Down Last 7 Days | N/A | N/A | N/A | N/A |
| Down Last 30 Days | N/A | N/A | N/A | N/A |
| Growth Estimates | BIOAF | Industry | Sector(s) | S&P 500 |
|---|
| Current Qtr. | N/A | N/A | N/A | N/A |
| Next Qtr. | N/A | N/A | N/A | N/A |
| Current Year | N/A | N/A | N/A | N/A |
| Next Year | N/A | N/A | N/A | N/A |
| Next 5 Years (per annum) | N/A | N/A | N/A | N/A |
| Past 5 Years (per annum) | N/A | N/A | N/A | N/A |
